drugset / Trial / NCT06200363
A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective, open, single-arm, investigator-initiated clinical study to evaluate the safety and efficacy of intravenous administration of T3011 at different doses in combination with oral regorafenib in the treatment of advanced colorectal cancer.
Timeline
- Start
- 2023-09-21
- Primary completion
- 2024-11
- Completion
- 2024-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Regorafenib | Small molecule | — | Oral |
| Subject | T3011 | Other / unclassified | — | Intravenous |